Polaryx Therapeutics, Inc. (PLYX)

NASDAQ: PLYX · Real-Time Price · USD

2.070

-0.070 (-3.27%)

At close: Aug 21, 2026, 4:00 PM EDT

2.066

-0.004 (-0.20%)

After-hours: Aug 21, 2026, 5:53 PM EDT

Polaryx Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	-	-	-	0.10
Net Debt / Equity Ratio	-1.05	-1.13	-0.98	0.10
Quick Ratio	13.22	8.50	15.99	0.00
Current Ratio	13.53	8.55	17.30	2.23
Return on Equity (ROE)	-96.56%	-193.70%	-1013.73%	-
Return on Assets (ROA)	-42.52%	-96.12%	-74.36%	-
Return on Capital Employed (ROCE)	-47.70%	-171.30%	-92.40%	-296.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Buyback Yield / Dilution	-13.11%	-32.81%	-219.94%	-

SEC Filings: 10-K · 10-Q